Chemo Not Needed for Most Early Breast Cancer: TAILORx Chemo Not Needed for Most Early Breast Cancer: TAILORx
Practice-changing results from the TAILORx trial have confirmed that about 70% of patients with hormone-positive early breast cancer will not benefit from adjuvant chemotherapy.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Health | Hematology | Hormones